Comparison of the effect of single and twice daily administration of ranitidine in relief of morning abdominal pain and nausea in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20171211037830N2

Enrollment

150

Registered

2018-07-05

Start date

2017-03-21

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abdominal pain and nausea. Unspecified abdominal pain

Interventions

Intervention 1: Intervention group1: single dose ranitidine. Intervention 2: Intervention group: two dose ranitidine.

Eligibility

Sex/Gender

All

Age

3 Years to 15 Years

Inclusion criteria

Inclusion criteria: abdominal pain and nausea

Exclusion criteria

Exclusion criteria: Nausea caused by extra-digestive system causes

Design outcomes

Primary

Measure	Time frame
Improvement in abdominal pain. Timepoint: Two weeks and four weeks after starting treatment. Method of measurement: Question from parents.;Improvement in nausea. Timepoint: Question from parents. Method of measurement: improvement in nausea.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sobhani Shahmirzadi

Gorgan University of Medical Sciences

sobhani@goums.ac.ir+98 17 3252 8435

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026